COST-EFFECTIVENESS OF SAXAGLIPTIN (ONGLYZA®) IN TYPE 2 DIABETES IN SOUTH AFRICA

被引：0
|
作者：
Juarez-Garcia, A. [1 ]
Casalvolone, D. [2 ]
Qatami, L. [3 ]
Bergenheim, K. [4 ]
Donato, B. M. K. [5 ]
机构：
[1] Bristol Myers Squibb Co, Mexico City, DF, Mexico
[2] Bristol Myers Squibb Co, Bedforview, South Africa
[3] Bristol Myers Squibb Co, Dubai, U Arab Emirates
[4] AstraZeneca, Molndal, Sweden
[5] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 04期
关键词：
D O I：
10.1016/j.jval.2012.03.974
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A180 / A180
页数：1
相关论文
共 50 条
  • [31] THE COST-EFFECTIVENESS ANALYSIS OF VIDALGLIPTIN IN TYPE 2 DIABETES IN POLAND
    Walczak, J.
    Nogas, G.
    Gebus, E.
    Pawlik, D.
    Pacocha, K.
    VALUE IN HEALTH, 2009, 12 (07) : A406 - A406
  • [32] Screening for type 2 diabetes mellitus: A cost-effectiveness analysis
    Hoerger, TJ
    Harris, R
    Hicks, KA
    Donahue, K
    Sorensen, S
    Engelgau, M
    ANNALS OF INTERNAL MEDICINE, 2004, 140 (09) : 689 - 699
  • [33] COST-EFFECTIVENESS OF LIRAGLUTIDE FOR SUBJECTS WITH TYPE 2 DIABETES IN SPAIN
    Ramirz de Arellano, A.
    Hunt, B.
    Mezquita Raya, P.
    Briones, T.
    Perez, A.
    Valentine, W. J.
    VALUE IN HEALTH, 2014, 17 (03) : A249 - A250
  • [34] COST-EFFECTIVENESS OF NEW ANTIDIABETICS IN TYPE 2 DIABETES: A REVIEW
    Baytar, S.
    Malhan, S.
    VALUE IN HEALTH, 2010, 13 (07) : A292 - A292
  • [35] The cost-effectiveness of insulin glulisine in type 2 diabetes in Poland
    Walczak, J.
    Dardzinski, W.
    Kusy, M.
    Lis, J.
    Nogas, G.
    VALUE IN HEALTH, 2008, 11 (03) : A226 - A226
  • [36] DRIVERS OF COST-EFFECTIVENESS IN TYPE-2 DIABETES MELLITUS
    McEwan, P.
    Foos, V
    Grant, D.
    Lamotte, M.
    Palmer, J. L.
    Lloyd, A.
    VALUE IN HEALTH, 2013, 16 (03) : A165 - A165
  • [37] Cost-effectiveness of a lifestyle intervention in preventing Type 2 diabetes
    Irvine, Lisa
    Barton, Garry R.
    Gasper, Amy V.
    Murray, Nikki
    Clark, Allan
    Scarpello, Tracey
    Sampson, Mike
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2011, 27 (04) : 275 - 282
  • [38] Cost-effectiveness issues in type 2 diabetes prevention in the USA
    Palmer, AJ
    Roze, S
    DIABETES, 2002, 51 : A279 - A279
  • [39] Cost-Effectiveness of Aliskiren in Type 2 Diabetes, Hypertension, and Albuminuria
    Delea, Thomas E.
    Sofrygin, Oleg
    Palmer, James L.
    Lau, Helen
    Munk, Veronica C.
    Sung, Jennifer
    Charney, Alan
    Parving, Hans-Henrik
    Sullivan, Sean D.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (10): : 2205 - 2213
  • [40] Assessment of the cost-effectiveness of influenza vaccination for type 2 diabetes
    Sorensen, S
    Gibbons, C
    Engelgau, M
    Narayan, KMV
    Hoerger, T
    Valdez, R
    Gregg, E
    Thompson, T
    Bethke, A
    DIABETES, 2003, 52 : A11 - A11
12345